Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels

Схожие документы

• Solution Structure of the Soluble Receptor for Advanced Glycation End Products (sRAGE)
  по: Sárkány, Zsuzsa, et al.
  Опубликовано: (2011)
• Effect of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and the Proinflammatory RAGE Ligand (EN-RAGE, S100A12) on Mortality in Hemodialysis Patients
  по: Nakashima, Ayumu, et al.
  Опубликовано: (2010)
• Over expression of toll-like receptors in peripheral blood and synovial fluid monocytes of enthesitis related arthritis category of juvenile idiopathic arthritis (JIA-ERA) patients contributes to secretion of inflammatory mediators
  по: Myles, Arpita, et al.
  Опубликовано: (2012)
• Purification and Characterization of Mouse Soluble Receptor for Advanced Glycation End Products (sRAGE)
  по: Hanford, Lana E., et al.
  Опубликовано: (2004)
• Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
  по: Pratte, Katherine A., et al.
  Опубликовано: (2021)